CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 783.00
-13.00 (-1.63%)
Jul 16, 2026, 9:25 AM JST
CanBas Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
15.21B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | 108.00M | -2.00M | -1.82% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RaQualia Pharma | 3.82B |
| ReproCELL | 2.23B |
| Immuno-Biological Laboratories | 1.00B |
| AnGes | 908.00M |
| Stella Pharma | 323.00M |
| SUSMED,Inc. | 274.00M |
| Nano Holdings | 174.00M |
| CellSeed | 161.00M |